| Pharmaceutical Companies | |||||||||||||||
| Name | FV | CMP | 52week High | 52week Low | Mkt Cap | Equity Cap | Networth | Total Debt | BV | Net Sales | PAT | EPS | P/E | P/BV | Promoter Holding |
| (Rs.) | (Rs.) | (Rs.) | (Rs.) | (Rs.Crs) | (Rs.Crs) | (Rs.Crs) | (Rs.Crs) | (Rs.) | (Rs.Crs) | (Rs.Crs) | (Rs.) | % | |||
| Indian | |||||||||||||||
| Sun Pharma | 1 | 421.55 | 678.8 | 350.4 | 101141 | 240 | 41409 | 9893 | 172.6 | 30091 | 2665 | 11.1 | 37.9 | 2.4 | 54.38 |
| Dr. Reddys Labs | 5 | 2611.95 | 2965.2 | 2017.2 | 43373 | 83 | 14024 | 3413 | 844.8 | 15786 | 1950 | 117.5 | 22.2 | 3.1 | 26.77 |
| Cipla | 2 | 537.9 | 678 | 483.75 | 43346 | 161 | 15012 | 4316 | 186.3 | 16839 | 1492 | 18.5 | 29.0 | 2.9 | 36.7 |
| Divis Labs | 2 | 1630 | 1769 | 1068.1 | 43237 | 53 | 6957 | 106 | 262.1 | 5102 | 1353 | 51.0 | 32.0 | 6.2 | 52.01 |
| Aurobindo Pharma | 1 | 569.25 | 838 | 546 | 33353 | 59 | 13891 | 6573 | 237.1 | 19679 | 2365 | 40.4 | 14.1 | 2.4 | |
| International | |||||||||||||||
| Glaxo SmithKline | 10 | 1159 | 1812 | 1131.05 | 19634 | 169 | 2140 | 0 | 126.3 | 3230 | 445 | 26.3 | 44.1 | 9.2 | 75 |
| Abbott India | 10 | 8646.05 | 8998.95 | 6900 | 18372 | 21 | 2009 | 0 | 945.2 | 3792 | 450 | 211.9 | 40.8 | 9.1 | 74.99 |
| Pfizer | 10 | 3102 | 3840 | 2490 | 14191 | 46 | 3011 | 3 | 658.2 | 2249 | 429 | 93.8 | 33.1 | 4.7 | 63.92 |
| AstraZeneca | 2 | 1839.7 | 2398.55 | 1306.8 | 4599 | 5 | 301 | 0 | 120.3 | 745 | 54 | 21.8 | 84.5 | 15.3 | 75 |
| Procter and Gamble | 10 | 4510 | 4995 | 2172 | 7486 | 17 | 1564 | 0 | 942.4 | 919 | 857 | 516.1 | 8.7 | 4.8 | 51.82 |
| Company & JSAlphaa | |||||||||||||||
Scrip Watch
Scrip Sanctuaries for protection from the wildlife in this jungle of Indian Equities